Ting, W., Helong, X., Meijian, Y., Jing, L., & Yang, Y. (2026). NR1D2 Knockdown Alleviates Myocardial Infarction through Nrf2 Signaling Pathway Activation.. Cardiovascular drugs and therapy.
Ting W, Helong X, Meijian Y, Jing L, Yang Y. NR1D2 Knockdown Alleviates Myocardial Infarction through Nrf2 Signaling Pathway Activation.. Cardiovascular drugs and therapy. 2026; PMID: 42081055
Ting W, Helong X, Meijian Y, et al. NR1D2 Knockdown Alleviates Myocardial Infarction through Nrf2 Signaling Pathway Activation.[J]. Cardiovascular drugs and therapy. 2026.
@article{ting2026,
author = {Wang Ting and Xiao Helong and Yang Meijian and Liu Jing and Yang Yang},
title = {NR1D2 Knockdown Alleviates Myocardial Infarction through Nrf2 Signaling Pathway Activation.},
journal = {Cardiovascular drugs and therapy},
year = {2026},
note = {PMID: 42081055},
}
TY - JOUR AU - Wang Ting AU - Xiao Helong AU - Yang Meijian AU - Liu Jing AU - Yang Yang TI - NR1D2 Knockdown Alleviates Myocardial Infarction through Nrf2 Signaling Pathway Activation. T2 - Cardiovascular drugs and therapy PY - 2026 AN - PMID:42081055 ER -
Ferroptosis contributes to myocardial infarction (MI) pathogenesis. However, the role of nuclear receptor subfamily 1 group D member 2 (NR1D2) in MI-associated ferroptosis and its potential interaction with nuclear factor erythroid 2-related factor 2 (Nrf2) pathway remains unclear. We sought to determine whether NR1D2 regulates ferroptosis in MI through the Nrf2 pathway and to evaluate the therapeutic potential of NR1D2 knockdown.